Metraipolis › archive › dc_b0f76b5908cb

Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42245720
DOI
10.3389/fonc.2026.1727389
License (as archived)
solo-consultazione
Archived
2026-11-01T13:10:47.543Z
SHA-256 of the archived text
bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23
Stable URL of this page
https://metraipolis.com/documento/dc_b0f76b5908cb

How to cite

Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720 — Europe PMC (en), https://europepmc.org/article/MED/42245720 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0f76b5908cb (Metraipolis archive dc_b0f76b5908cb, sha256 bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23)
BibTeX
@misc{dcb0f76b5908cb,
  title = {Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245720},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0f76b5908cb; sha256 bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245720. Agents can read the archived copy with the MCP tool read_document.